- Home
- SNTI vs CSCI Comparison
SNTI vs CSCI Comparison
Compare SNTI & CSCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNTI
- CSCI
- Stock Information
- Founded
- SNTI 2016
- CSCI 1990
- Country
- SNTI United States
- CSCI Canada
- Employees
- SNTI 48
- CSCI N/A
- Industry
- SNTI Biotechnology: Pharmaceutical Preparations
- CSCI
- Sector
- SNTI Health Care
- CSCI
- Exchange
- SNTI Nasdaq
- CSCI NYSE
- Market Cap
- SNTI 18.2M
- CSCI 11.1M
- IPO Year
- SNTI N/A
- CSCI 1996
- Fundamental
- Price
- SNTI $3.97
- CSCI $2.50
- Analyst Decision
- SNTI Strong Buy
- CSCI
- Analyst Count
- SNTI 1
- CSCI 0
- Target Price
- SNTI $12.00
- CSCI N/A
- AVG Volume (30 Days)
- SNTI 7.2M
- CSCI 4.0K
- Earning Date
- SNTI 11-14-2024
- CSCI 11-12-2024
- Dividend Yield
- SNTI N/A
- CSCI N/A
- EPS Growth
- SNTI N/A
- CSCI N/A
- EPS
- SNTI N/A
- CSCI N/A
- Revenue
- SNTI N/A
- CSCI $4,834,000.00
- Revenue This Year
- SNTI $254.47
- CSCI N/A
- Revenue Next Year
- SNTI $169.66
- CSCI N/A
- P/E Ratio
- SNTI N/A
- CSCI N/A
- Revenue Growth
- SNTI N/A
- CSCI N/A
- 52 Week Low
- SNTI $1.52
- CSCI $2.50
- 52 Week High
- SNTI $16.94
- CSCI $11.10
- Technical
- Relative Strength Index (RSI)
- SNTI 47.37
- CSCI N/A
- Support Level
- SNTI $3.60
- CSCI N/A
- Resistance Level
- SNTI $5.96
- CSCI N/A
- Average True Range (ATR)
- SNTI 1.02
- CSCI 0.00
- MACD
- SNTI -0.29
- CSCI 0.00
- Stochastic Oscillator
- SNTI 5.74
- CSCI 0.00
About SNTI Senti Biosciences Inc.
Senti Biosciences Inc is a clinical-stage biotechnology company developing next-generation cell and gene therapies engineered with their gene circuit platform technologies to fight challenging diseases. The product candidates utilize allogeneic chimeric antigen receptor natural killer (CAR-NK) cells outfitted with its gene circuit technologies in various oncology indications. The company product candidates include SENTI-202, a Logic Gated off-the-shelf CAR-NK cell therapy designed to target and eliminate cancer cells while sparing the healthy bone marrow; and SENTI-301A for the treatment of hepatocellular carcinoma.
About CSCI COSCIENS BIOPHARMA INC
Cosciens Biopharma Inc is a biopharmaceutical company developing and commercializing a diversified portfolio of pharmaceutical and diagnostic products and active ingredients for healthcare and cosmetics industries. The company is engaged in the development of therapeutic assets and proprietary extraction technology.